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Introduction / objectives
We aimed to determine the prevalence and acquisition
rate of ESBL-GNO amongst patients admitted to general
medical units at our hospital.
Methods
Patients consecutively admitted to 13 medical wards
from March-June 2010 were screened for ESBL-GNO
via rectal swab within 48hours of admission, and 36
hours of discharge.
Results
Of 1967 patients, swabs were obtained in 1111(56%) at
admission and 491(25%) at discharge with 441(22%)
having both. Mean age was 64 years and 58% were
male. 6.8% (75/1111) of patients were positive for an
ESBL-GNO at admission of whom 86%, for whom data
were available (24/28), had an ESBL-GNO detected in
the previous 6 months. 3.7%(18/487) of patients
acquired an ESBL-GNO, having positive cultures at dis-
charge but not at admission. On univariate regression,
acquisition of an ESBL-GNO was associated with admis-
sion from home (OR 0.2 [95%CI 0.1-0.6], p=.005), trans-
fer from another unit (OR 8.3[95% CI 2-33], p=.003)
and receipt of a first or second-generation cephalosporin
(OR 7.2 [95% CI 1-37],p=.017). Receipt of a first or sec-
ond-generation cephalosporin was the only factor inde-
pendently associated with ESBL-GNO acquisition (OR
7.1[95% CI 1-40], p=.03). Age, sex, intensive care,
provenance and receipt of other antibiotics were not
associated with ESBL carriage or acquisition.
Conclusion
Carriage and acquisition of ESBL-GNO is a problem
amongst medical patients at our hospital. No risk factors
for ESBL-GNO carriage were identified.
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